Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Swiss Center for Clinical Movement Analysis
Received: 4 May 2020
Accepted: 24 September 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: The study design and protocol were approved by the institutional review board of ETH Zurich (EK 2018-N-31) and classified as a non-interventional trial, thereby excluding it from trial registration. All participants gave their informed consent prior to participating in the study.
: We obtained written consent to the publication of study results and images (where applicable) from all participants.
: FLH, PW and MX have no competing interests to declare. KS, JED and RR are authors of the European patent application 16207252.4 filed by ETH Zurich and licensed by MyoSwiss AG. KS is co-founder and CTO of MyoSwiss AG. JED is co-founder and CEO of MyoSwiss AG.